Literature DB >> 3156804

Improved technique for the expression of fragile-X in cultured amniotic fluid cells.

H von Koskull, P Aula, P Ammälä, A M Nordström, J Rapola.   

Abstract

An improved technique for inducing fra(X) expression in cultured cells was obtained by using diazepam for mitotic arrest and 5-fluorodeoxyuridine (FUdR) for the induction of fra(X) expression. The method was developed using cultured fibroblast and urinary cells from fra(X) patients. Prenatal studies were performed on cultured amniotic fluid cells in five pregnancies at risk for fra(X). In two cases the cultured cells showed a 46,XY, fra(X) karyotype. One of the pregnancies was terminated and the diagnosis was confirmed by chromosome studies on several fetal tissues including chorionic villi and by histopathologic changes in the lymphatic vessels of the fetal testes. The fra(X) was also demonstrated in chorionic villi in a case in which amniotic fluid cells were not studied. Chorionic villi were isolated after a spontaneous abortion, the cultured cells had a 45,X karyotype and in addition 5% of the cells were fra(X) positive.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3156804     DOI: 10.1007/bf00293028

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  24 in total

1.  Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium.

Authors:  G R Sutherland
Journal:  Science       Date:  1977-07-15       Impact factor: 47.728

2.  Fragile X in a normal male: a cautionary tale.

Authors:  M G Daker; P Chidiac; C N Fear; A C Berry
Journal:  Lancet       Date:  1981-04-04       Impact factor: 79.321

3.  Feasibility of fragile X chromosome prenatal diagnosis demonstrated.

Authors:  E C Jenkins; W T Brown; C J Duncan; J Brooks; M Ben-Yishay; F M Giordano; H M Nitowsky
Journal:  Lancet       Date:  1981-12-05       Impact factor: 79.321

4.  Transmission of fragile (X) (q27) site from a male.

Authors:  G C Webb; J G Rogers; D B Pitt; J Halliday; T Theobald
Journal:  Lancet       Date:  1981-11-28       Impact factor: 79.321

5.  Prenatal diagnosis of Martin-Bell syndrome associated with fragile site at Xq27-28.

Authors:  T Webb; D Butler; J Insley; J B Weaver; S Green; C Rodeck
Journal:  Lancet       Date:  1981 Dec 19-26       Impact factor: 79.321

6.  Cultured human amniotic fluid cells characterized with antibodies against intermediate filaments in indirect immunofluorescence microscopy.

Authors:  I Virtanen; H von Koskull; V P Lehto; T Vartio; P Aula
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

7.  The fragile X(q27) form of X-linked mental retardation: FUdR as an inducing agent for fra(X)(q27) expression in lymphocytes, fibroblasts, and amniocytes.

Authors:  R Brookwell; A Daniel; G Turner; J Fishburn
Journal:  Am J Med Genet       Date:  1982-10

8.  Expression in lymphocyte and fibroblast culture of the fragile X chromosome: a new technical approach.

Authors:  M G Mattei; J F Mattei; I Vidal; F Giraud
Journal:  Hum Genet       Date:  1981       Impact factor: 4.132

9.  Prenatal diagnosis of fragile X in a heterozygous female fetus and postnatal follow-up.

Authors:  M G Wilson; C A Marchese
Journal:  Prenat Diagn       Date:  1984 Jan-Feb       Impact factor: 3.050

10.  FUdR induction of the X chromosome fragile site: evidence for the mechanism of folic acid and thymidine inhibition.

Authors:  T W Glover
Journal:  Am J Hum Genet       Date:  1981-03       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.